Chemogenomics approaches to rationalising compound action of traditional Chinese and Ayurvedic medicines by Fauzi, Fazlin M et al.
POSTER PRESENTATION Open Access
Chemogenomics approaches to rationalising
compound action of traditional Chinese and
Ayurvedic medicines
Fazlin Mohd Fauzi1,2, Alexios Koutsoukas1, Rob Lowe3, Kalpana Joshi4, Tai-Ping Fan5, Andreas Bender1*
From 8th German Conference on Chemoinformatics: 26 CIC-Workshop
Goslar, Germany. 11-13 November 2012
Traditional Chinese medicine (TCM) and Ayurveda have
been used in humans for thousands of years [1]. While the
link to a particular indication has been established in man,
the mode-of-action (MOA) of the formulations is relatively
unknown. In this study, we aim to understand the MOA of
formulations used in traditional medicine using in silico
target prediction tools, which predicts protein targets
(hence, MOAs) given the chemical structure of a com-
pound. We were able to establish several links between
suggested MOAs and experimental evidence. In particular,
compounds from the ‘tonifying and replenishing medicinal’
class exhibit a hypoglycemic effect [2] which can be con-
nected to SGLT 1 and 2 [3] and PTP1B [4]. Similar results
were obtained with Ayurvedic anti-cancer drugs. Here,
both primary anti-cancer targets, which directly participate
in cancer pathogenesis, i.e. steroid-5-alpha-reductase 1 and
2 were predicted, as well as synergistic targets, i.e. P-glyco-
protein (blocking this efflux pump increases intracellular
concentration of the primary active ingredient) [5]. In addi-
tion, some targets may point us to possible novel MOA
and side effects. Most notably, GPBAR1 which was pre-
dicted as a target for both ‘tonifying and replenishing med-
icinal’ and anti-cancer classes, suggest an influence of the
compounds on metabolism [6]. Understanding the MOA
of these compounds is beneficial as it can provide new
resources for NME, with higher efficacies in the clinic than
in the current drug discovery setting. This can be a promis-
ing endeavor as the phenotypes of these compounds are
well known which indicates both the therapeutic impact
and efficacy against a certain disease.
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